- Investing Ideas
- U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
9
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
9 companies
Natera
Market Cap: US$39.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$277.37
7D
1.1%
1Y
86.9%
AbbVie
Market Cap: US$432.5b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$244.11
7D
-3.4%
1Y
28.1%
Merck
Market Cap: US$298.3b
Operates as a healthcare company worldwide.
MRK
US$123.61
7D
-1.9%
1Y
50.0%
Travere Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$56.74
7D
-2.8%
1Y
240.6%
Mesa Laboratories
Market Cap: US$522.9m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$94.68
7D
3.6%
1Y
19.8%
Sotera Health
Market Cap: US$5.1b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.15
7D
3.9%
1Y
61.6%
SIGA Technologies
Market Cap: US$245.3m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$3.56
7D
0.6%
1Y
-47.5%
BioLife Solutions
Market Cap: US$1.4b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$29.15
7D
7.2%
1Y
38.5%
Waters
Market Cap: US$37.0b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$374.92
7D
1.8%
1Y
29.5%